Michael Khan

Director Ejecutivo en

Argonaute RNA Ltd.

Commercial Services

Consumer Services

Perfil

Michael Khan is currently the Chief Executive Officer at Argonaute RNA Ltd. He is also a Member at Diabetes UK and HEART UK.
Previously, he served as the Executive Director & Chief Medical Officer at Silence Therapeutics Plc from 2013 to 2016.
He also held the position of Head-Molecular Medicine & Associate Professor at the University of Warwick.
Dr. Khan holds a doctorate degree from University College London.

Cargos activos de Michael Khan

Empresas	Cargo	Inicio
HEART UK	Corporate Officer/Principal	-
Diabetes UK	Corporate Officer/Principal	-
Argonaute RNA Ltd. Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells	Director Ejecutivo	01/01/2021

Todos los cargos activos de Michael Khan

Antiguos cargos conocidos de Michael Khan.

Empresas	Cargo	Fin
SILENCE THERAPEUTICS PLC	Director Técnico/Científico/I+D	17/06/2016
University of Warwick University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Michael Khan.

Formación de Michael Khan.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Khan.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
Silence Therapeutics Plc Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products	Commercial Services
University of Warwick University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University College London University College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Diabetes UK
HEART UK
Argonaute RNA Ltd. Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells	Commercial Services